Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This study is a two arm, randomized, prospective, multicenter study on the perioperative treatment of locally advanced resectable esophageal cancer with penpulimab combined with anlotinib hydrochloride and chemotherapy.
Epistemonikos ID: bf4a4f574714910f433068f0832c64ce354835b7
First added on: Oct 01, 2024